Girindus Taps Marina For Oligo Technology | Chemical & Engineering News
Volume 90 Issue 22 | pp. 26-27 | Concentrates
Issue Date: May 28, 2012

Girindus Taps Marina For Oligo Technology

Department: Business
Keywords: oligonucleotides, contract manufacturing

Marina Biotech and Girindus have formed an alliance in which Girindus, a German firm with U.S. operations in Cincinnati, will have exclusive rights to develop, supply, and commercialize oligonucleotide constructs using Marina’s conformationally restricted nucleotide (CRN) technology. Marina, based in Bothell, Wash., will receive royalties from the sale of CRN-based oligo­nucleotide reagents as well as a supply of current Good Manufacturing Practices-certified material for its clinical trials and those run by its partners.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment